ArticleInternal medicine (Tokyo, Japan)2026

The Effectiveness of Elranatamab in the Management of Refractory Multiple Myeloma with Central Nervous System Involvement.

Misaki Uemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.